Focus: Jaguar Gene Therapy is a public biotech company focused on AAV-based gene therapies, headquartered in Lake Forest, Illinois. The company operates as a clinical-stage developer with a concentrated pipeline in rare genetic diseases.
Profile data last refreshed 13h ago · AI intelligence enriched 2mo ago
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Jaguar is a speculative early-stage gene therapy play best suited for scientists seeking R&D impact over near-term career growth or compensation stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Jaguar Gene Therapy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Jaguar Gene Therapy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles